Khulud Alhazmi | Medicine and Health Sciences | Innovative Research Award

Published on by Computer Scientists Awards

Innovative Research Award

Khulud Alhazmi
Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Saudi Arabia.

Khulud Alhazmi
Affiliation Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University
Country Saudi Arabia
Scopus ID 57224867322
Documents 21
Citations 216
h-index 8
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0009-0001-3980-1177

Khulud Alhazmi is a researcher specializing in microbiology, infectious diseases, antimicrobial resistance, and public health. Her scholarly work emphasizes clinically significant bacterial pathogens, diagnostic microbiology, infection prevention, antimicrobial stewardship, and healthcare worker awareness of emerging infectious diseases. Through peer-reviewed publications and collaborative investigations, her research contributes to evidence-based clinical practice and healthcare policy development.[1]

Abstract

This article summarizes the academic profile of Khulud Alhazmi in recognition of contributions to microbiology and infectious disease research. Her publications examine antimicrobial resistance, diagnostic laboratory methodologies, healthcare-associated infections, and emerging viral diseases. The combination of laboratory investigations and public health studies reflects an interdisciplinary approach that supports improved clinical decision-making and infection control practices within healthcare environments.[2]

Keywords

  • Microbiology
  • Antimicrobial Resistance
  • Healthcare Epidemiology
  • Diagnostic Microbiology
  • Medicine and Health Sciences

Introduction

Modern infectious disease research requires continuous monitoring of resistant pathogens, rapid diagnostic technologies, and public health preparedness. Khulud Alhazmi’s academic work addresses these priorities through studies that investigate bacterial resistance mechanisms, healthcare worker knowledge, and laboratory innovations. Her publications provide clinically relevant information supporting evidence-based healthcare management and improved patient safety.[3]

Research Profile

According to the provided academic metrics, the researcher has produced 21 indexed publications with 216 citations and an h-index of 8. These indicators demonstrate sustained scholarly productivity and measurable scientific influence within medicine and health sciences. Research collaborations focus on clinically important microorganisms, antimicrobial therapies, diagnostic optimization, and epidemiological surveillance.[4]

Research Contributions

  • Investigation of multidrug-resistant bacterial pathogens.
  • Evaluation of diagnostic screening methodologies.
  • Studies addressing healthcare worker awareness and vaccination acceptance.
  • Reviews of antimicrobial treatment strategies and biofilm-associated infections.

Publications

  1. The Willingness of Healthcare Workers in Makkah, Saudi Arabia, to Be Vaccinated Against Monkeypox and Their Knowledge About Monkeypox (Vaccines, 2026).
  2. Hypervirulent and Drug-Resistant Klebsiella pneumoniae: Clinical Challenges and Alternative Treatment Strategies.
  3. Balancing Diagnostic Sensitivity and Operational Efficiency in MRSA Screening Using GeneXpert.
  4. A Review of Vancomycin Role in Gram Positive Biofilm-Associated Infections.

Research Impact

The published research contributes to improved understanding of antimicrobial resistance, healthcare-associated infections, and infectious disease preparedness. By integrating laboratory science with public health perspectives, these studies provide practical evidence supporting infection prevention strategies, optimized diagnostics, and informed clinical interventions. Such work is relevant for healthcare institutions seeking improved patient outcomes and enhanced epidemiological surveillance.[5]

Award Suitability

The research profile demonstrates consistent publication activity, meaningful citation performance, and contributions addressing important healthcare challenges. The combination of original investigations, clinical reviews, and public health studies reflects a balanced academic portfolio suitable for consideration within an Innovative Research Award evaluation framework based on scholarly merit, scientific relevance, and research impact.[6]

Conclusion

Khulud Alhazmi has established a focused research portfolio centered on microbiology, antimicrobial resistance, infectious disease epidemiology, and diagnostic innovation. Her published work supports clinical practice, strengthens healthcare knowledge, and contributes to the advancement of medicine and health sciences through evidence-based research and interdisciplinary collaboration.

External Links

References

  1. Vaccines. The Willingness of Healthcare Workers in Makkah, Saudi Arabia, to Be Vaccinated Against Monkeypox and Their Knowledge About Monkeypox. 10.3390/vaccines14070603.
  2. International Journal of General Medicine. Hypervirulent and Drug-Resistant Klebsiella pneumoniae.
    10.2147/IJGM.S548733.
  3. Journal of King Abdulaziz University: Medical Sciences. Balancing Diagnostic Sensitivity and Operational Efficiency in MRSA Screening Using GeneXpert. Journal Link.
  4. Therapeutics and Clinical Risk Management. Vancomycin Role in Gram Positive Biofilm-Associated Infections.
    10.2147/TCRM.S541780.
  5. Scopus Author Metrics. Research profile for Scopus Author ID 57224867322.
    https://www.scopus.com/authid/detail.uri?authorId=57224867322
  6. Computer Scientists Awards. Award evaluation framework and academic recognition information.

Hasan Obeidat | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Hasan Obeidat
Affiliation MedStar Health Georgetown University (Baltimore) Program
Country United States
Google Scholar ID ACstYckAAAAJ&hl
Documents 10
Citations 98
h-index 3
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards

Hasan Obeidat

MedStar Health Georgetown University (Baltimore) Program

Hasan Obeidat is a researcher in the field of Medicine and Health Sciences whose scholarly activities emphasize clinical research, case-based medical investigations, surgery, oncology, pathology, and internal medicine. His publications demonstrate an interdisciplinary approach to addressing complex healthcare challenges while contributing to evidence-based clinical practice. Through collaborations with multidisciplinary research teams, he has participated in studies involving surgical outcomes, rare disease presentations, prognostic biomarkers, and diagnostic pathology, reflecting an academic commitment to improving patient care and medical knowledge.[1]

Abstract

Hasan Obeidat’s academic portfolio reflects contributions to clinical medicine through collaborative investigations addressing surgery, oncology, hematology, pathology, endocrinology, and women’s health. His publications combine retrospective analyses with case reports and clinical evaluations to improve diagnosis, therapeutic decision-making, and patient outcomes. The available scholarly record indicates sustained participation in multidisciplinary research projects published in peer-reviewed journals while maintaining an emphasis on clinically relevant evidence.[1]

Keywords

Medicine, Clinical Research, Surgery, Oncology, Pathology, Internal Medicine, Case Reports, Healthcare Research, Prognostic Biomarkers, Patient Outcomes.

Introduction

Modern clinical research depends upon multidisciplinary collaboration and careful evaluation of patient outcomes. Hasan Obeidat has contributed to this objective through studies examining major lower extremity amputation, febrile neutropenia prognosis, rare gynecological disorders, cardiac pathology, and metabolic neurological complications. These investigations provide clinically meaningful observations that may support improved diagnostic accuracy and treatment strategies within healthcare settings.[2]

Research Profile

The research profile demonstrates approximately 10 indexed scholarly publications with 98 citations and an h-index of 3. The published work spans surgery, therapeutic risk management, pathology, internal medicine, and women’s health. Collaboration with diverse clinical specialists illustrates active participation in evidence-based medical research and interdisciplinary scientific communication.[1]

Research Contributions

  • Investigated outcomes of major lower extremity amputation in a tertiary referral center.
  • Reported uncommon presentations of ovarian fibrothecoma through peer-reviewed case studies.
  • Evaluated monocytopenia as a prognostic biomarker in chemotherapy-induced febrile neutropenia.
  • Contributed to diagnostic evaluation of cardiac angiosarcoma and pathological interpretation.
  • Published recent clinical observations involving diabetic striatopathy and endocrine complications.

Publications

  • Major lower extremity amputation: a contemporary analysis from an academic tertiary referral centre in a developing community (2019).
  • A rare presentation of ovarian fibrothecoma in a middle age female: case report (2019).
  • Evaluating the prognostic role of monocytopenia in chemotherapy-induced febrile neutropenia patients (2021).
  • Diagnostic Pitfall in Cardiac Angiosarcoma (2026).
  • When Hyperglycemia Moves the Body: A Case of Diabetic Striatopathy (2026).

Research Impact

The available citation metrics indicate that Hasan Obeidat’s work has attracted scholarly attention, particularly within surgery and clinical medicine. Research on amputation outcomes and prognostic biomarkers has supported discussion regarding patient management, while more recent case reports contribute valuable documentation of uncommon clinical presentations. Such publications enrich the medical literature by expanding clinical awareness and encouraging further investigation.[3]

Award Suitability

Based on the documented publication record, interdisciplinary collaborations, measurable citation performance, and contributions to clinically significant medical topics, Hasan Obeidat demonstrates characteristics commonly considered during evaluations for academic research recognition. His scholarly activities reflect continuous engagement with evidence-based medicine, scientific dissemination, and healthcare improvement, supporting consideration for the Best Researcher Award within an academic recognition framework.[4]

Conclusion

Hasan Obeidat has established a developing academic profile through collaborative medical research addressing surgery, pathology, oncology, and internal medicine. His peer-reviewed publications, measurable scholarly metrics, and commitment to clinically applicable investigations contribute to contemporary medical knowledge. Continued research activity and interdisciplinary collaboration are expected to further strengthen his scientific impact and professional recognition within Medicine and Health Sciences.[5]

References

  1. Google Scholar. (n.d.). Hasan Obeidat Citation Profile.
    https://scholar.google.co.uk/citations?user=ACstYckAAAAJ&hl=en&oi=ao
  2. Major lower extremity amputation: a contemporary analysis from an academic tertiary referral centre in a developing community.
    https://doi.org/10.1186/s12893-019-0638-5
  3. A rare presentation of ovarian fibrothecoma in a middle age female: case report.
    https://doi.org/10.2147/IJWH.S188611
  4. Evaluating the prognostic role of monocytopenia in chemotherapy-induced febrile neutropenia patients treated with granulocyte colony-stimulating factor.
    https://doi.org/10.2147/TCRM.S309132
  5. Computer Scientists Awards. (n.d.). Best Researcher Award.
    https://computerscientists.net

Federica Guglielmi | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Federica Guglielmi
Affiliation Catholic University of Sacred Heart
Country Italy
Scopus ID 57203429488
Documents 21
Citations 276
h-index 10
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0000-0002-1812-0479

Federica Guglielmi
Catholic University of Sacred Heart,Italy

Federica Guglielmi is an Italian researcher whose scholarly activities focus on pediatric dentistry, orthodontics, craniofacial development, sleep-disordered breathing, and multidisciplinary clinical management. Her research integrates evidence-based dentistry with sleep medicine to improve diagnosis and treatment planning for pediatric patients presenting with complex developmental and genetic conditions. Through peer-reviewed publications and collaborative clinical investigations, she has contributed to the understanding of orthodontic interventions, obstructive sleep apnea risk, and rare syndromic disorders. Her publication record, citation profile, and sustained academic engagement demonstrate meaningful contributions to contemporary medicine and health sciences.[1]

Abstract

This article summarizes the academic profile of Federica Guglielmi in relation to the Best Researcher Award. Her work emphasizes translational clinical research in orthodontics, pediatric oral health, and sleep-disordered breathing. Recent publications demonstrate the application of multidisciplinary diagnostic strategies for rare genetic syndromes, dental anomalies, and obstructive sleep apnea risk in children. The combination of clinical case reporting, retrospective analyses, and collaborative research reflects a commitment to improving patient-centered healthcare while advancing scientific knowledge.[2]

Keywords

Orthodontics, Pediatric Dentistry, Sleep-Disordered Breathing, Obstructive Sleep Apnea, Craniofacial Development, Rare Diseases, Clinical Research, Medicine and Health Sciences.

Introduction

Modern orthodontic research increasingly incorporates interdisciplinary approaches that combine dental science, genetics, sleep medicine, and pediatric healthcare. Federica Guglielmi’s publications illustrate this evolving perspective by addressing complex clinical conditions requiring integrated assessment and individualized therapeutic planning. Her investigations contribute to improved diagnostic accuracy and evidence-informed management of patients with developmental anomalies and sleep-related disorders.[3]

Research Profile

According to the provided scholarly metrics, the researcher has authored 21 indexed publications with 276 citations and an h-index of 10. Her research portfolio includes case reports, retrospective clinical investigations, and collaborative studies focusing on orthodontic treatment outcomes, pediatric sleep-disordered breathing, and oral manifestations associated with rare syndromes. These indicators demonstrate sustained scientific productivity and interdisciplinary collaboration within medicine and health sciences.[1]

Research Contributions

  • Advanced multidisciplinary evaluation of pediatric sleep-disordered breathing.
  • Published clinical reports involving Gorlin–Goltz syndrome, Cantù syndrome, and Infantile Refsum disease.
  • Investigated orthodontic treatment accuracy using different attachment designs.
  • Contributed to research on obstructive sleep apnea risk and bruxism in children with autism spectrum disorders.

Publications

  • Multidisciplinary Orthodontic and Home Sleep Apnea Testing-Based Assessment of Sleep-Disordered Breathing in a Pediatric Patient with Gorlin–Goltz Syndrome.
  • Cantù Syndrome: A Case Report With Orthodontic and Sleep Disorder Findings.
  • Prevalence of OSA Risk and Bruxism in Children With Autism Spectrum Disorders.
  • The Accuracy of Maxillary Canines’ Rotation with Different Attachment Designs.

Research Impact

The research outputs have strengthened clinical understanding of pediatric orthodontics and sleep medicine by integrating dental diagnostics with multidisciplinary healthcare. Citation indicators and collaborative publications suggest that the work has gained recognition within specialized research communities while supporting improved clinical decision-making and evidence-based patient management.[4]

Award Suitability

Federica Guglielmi’s scholarly achievements align with the objectives of the Best Researcher Award by demonstrating sustained publication activity, measurable citation impact, interdisciplinary collaboration, and clinically relevant scientific contributions. Her work promotes innovation in pediatric oral healthcare and strengthens knowledge translation between orthodontics, sleep medicine, and multidisciplinary clinical practice.[5]

Conclusion

The academic record presented here reflects a researcher actively contributing to medicine and health sciences through clinically relevant, collaborative, and evidence-based investigations. Continued research in pediatric orthodontics and sleep-disordered breathing is expected to further support advances in patient care, making this profile an appropriate example of scholarly excellence recognized through academic award programs.

References

  1. Elsevier. Scopus Author Details: Federica Guglielmi, Author ID 57203429488.
    https://www.scopus.com/authid/detail.uri?authorId=57203429488
  2. Guglielmi F., et al. Multidisciplinary Orthodontic and Home Sleep Apnea Testing-Based Assessment of Sleep-Disordered Breathing. Oral (2026). DOI:
    https://doi.org/10.3390/oral6040078
  3. Guglielmi F., et al. Cantù Syndrome: A Case Report With Orthodontic and Sleep Disorder Findings. Clinical Case Reports (2026).
    https://doi.org/10.1002/ccr3.72231
  4. Alessandri-Bonetti A., et al. Prevalence of OSA Risk and Bruxism in Children With Autism Spectrum Disorders. Autism Research (2026).
    https://doi.org/10.1002/aur.70149
  5. Staderini E., et al. The Accuracy of Maxillary Canines’ Rotation with Different Attachment Designs. Journal of Clinical Medicine (2026).
    https://doi.org/10.3390/jcm15020632

Bosco Paes | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Bosco Paes
Affiliation McMaster University
Country Canada
Scopus ID 35460184000
Documents 232
Citations 8,787
h-index 46
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards

Bosco Paes
McMaster University, Canada

Bosco Paes is a Canadian physician-scientist and academic whose research has significantly contributed to neonatal medicine, respiratory syncytial virus (RSV) prevention, neonatal infectious diseases, and evidence-based pediatric healthcare. His scholarly record demonstrates sustained contributions through multicenter clinical studies, systematic reviews, health economic analyses, and international collaborations. With an extensive publication portfolio, substantial citation impact, and an h-index reflecting consistent scientific influence, his research continues to support advances in neonatal clinical practice and healthcare policy.[1]

Abstract

The academic achievements of Bosco Paes demonstrate sustained excellence in pediatric and neonatal medicine, particularly in the prevention and management of respiratory syncytial virus infections among vulnerable infant populations. His investigations integrate clinical medicine, systematic evidence synthesis, and health economics to improve patient outcomes and healthcare resource utilization. Through collaborations with international experts, his publications have influenced preventive strategies and contributed to the scientific understanding of RSV prophylaxis, neonatal intensive care, and pediatric infectious diseases.[2]

Keywords

Neonatology, Pediatrics, Respiratory Syncytial Virus, RSV Prophylaxis, Palivizumab, Nirsevimab, Neonatal Medicine, Health Economics, Systematic Review, Evidence-Based Medicine.

Introduction

Research in neonatal healthcare requires multidisciplinary collaboration and rigorous evaluation of preventive interventions. Bosco Paes has contributed extensively to this field by combining clinical expertise with population-based research and economic evaluations. His work addresses clinically important issues affecting premature infants and supports informed healthcare decisions through robust scientific evidence.[3]

Research Profile

Bosco Paes has authored more than 230 indexed scholarly documents and accumulated nearly nine thousand citations according to Scopus metrics. His research spans neonatal intensive care, pediatric infectious diseases, RSV immunoprophylaxis, epidemiology, health services research, and evidence synthesis. The consistency of his scientific productivity demonstrates long-term engagement in internationally recognized clinical research programs.[1]

Research Contributions

His recent scholarly work includes evaluations of risk factor-guided RSV prophylaxis in Colombian preterm infants, comparative meta-analyses assessing palivizumab and nirsevimab effectiveness, and expert consensus recommendations through the ARMADA Taskforce. These studies integrate clinical evidence with economic analyses and international consensus to improve preventive pediatric healthcare.[4]

Publications

  • Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants. Cost Effectiveness and Resource Allocation, 2026.
  • Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants. Human Vaccines & Immunotherapeutics, 2026.
  • Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA Taskforce, 2026.

Research Impact

The research output of Bosco Paes has informed neonatal clinical practice, preventive immunization strategies, and evidence-based healthcare policies internationally. His collaborations with clinicians, epidemiologists, and health economists have strengthened the translation of scientific findings into practical recommendations for high-risk infant populations. The citation record and publication consistency indicate substantial scholarly influence within pediatric medicine.[5]

Award Suitability

Bosco Paes demonstrates the characteristics commonly associated with distinguished research recognition through sustained scholarly productivity, international collaborations, measurable citation impact, and contributions to neonatal healthcare. His work exemplifies rigorous clinical investigation, interdisciplinary cooperation, and the practical application of scientific evidence for improving patient care, making him a suitable candidate for consideration under the Best Researcher Award category.[6]

Conclusion

The academic profile of Bosco Paes reflects sustained excellence in pediatric and neonatal research with particular emphasis on respiratory syncytial virus prevention and neonatal healthcare. His publication record, collaborative research activities, and measurable scientific impact illustrate meaningful contributions to medical science and evidence-based clinical practice. Collectively, these achievements support recognition within international academic award programs dedicated to research excellence.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Bosco Paes, Author ID 35460184000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35460184000
  2. Rodríguez-Martínez CE, Ordóñez JE, Carbonell-Estrany X, Tarride JE, Paes BA. (2026). Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants.
    https://doi.org/10.1186/s12962-026-00001-0
  3. Fullarton JR, Paes BA, Waghorne N, et al. (2026). Meta-analysis of the efficacy of palivizumab versus nirsevimab.
  4. Manzoni P, Baraldi E, Midulla F, et al. (2026). ARMADA Taskforce Systematic Review and Expert Consensus on RSV Prevention.
  5. Computer Scientists Awards. Best Researcher Award evaluation framework.
    https://computerscientists.net/

Janaina Lemos | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Janaina Lemos
Federal University of Minas Gerais,Brazil

  Janaina Lemos
Affiliation Federal University of Minas Gerais
Country Brazil
Scopus ID 50262115100
Documents 12
Citations 115
h-index 6
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards

Janaina Lemos is a Brazilian researcher whose scholarly profile reflects sustained contributions to medicine and health sciences. Her research record, indexed through Scopus Author ID 50262115100, demonstrates engagement in biomedical and clinical investigations with measurable scholarly impact. The combination of peer-reviewed publications, citation performance, and interdisciplinary collaborations illustrates an active participation in advancing scientific knowledge within health-related disciplines.[1]

Abstract

This article presents an academic overview of Janaina Lemos and her research achievements within the field of medicine and health sciences. Drawing upon bibliometric indicators and published scientific outputs, the profile highlights her contributions to biomedical research, collaborative scholarship, and evidence-based scientific advancement. The analysis also considers her suitability for recognition through the Best Researcher Award presented by the Computer Scientists Awards program.[1]

Keywords

Medicine, Health Sciences, Biomedical Research, Osteoarthritis, Scientific Publications, Citation Impact, Academic Recognition, Research Excellence.

Introduction

Academic excellence is frequently assessed through research productivity, citation influence, and contributions to scientific progress. Janaina Lemos has established a documented scholarly presence through peer-reviewed publications and collaborative investigations focused on medical and health-related challenges. Her work contributes to the broader understanding of disease mechanisms, therapeutic interventions, and healthcare outcomes.[2]

Research Profile

According to indexed bibliometric records, Janaina Lemos has authored 12 scholarly documents that have collectively received 115 citations, resulting in an h-index of 6. These indicators suggest consistent engagement with topics relevant to medicine and health sciences and demonstrate the visibility of her work within the scientific community.[1]

Research Contributions

Her research contributions include participation in studies addressing musculoskeletal disorders, therapeutic interventions, and translational health science applications. Notably, published investigations involving osteoarthritis models have explored innovative treatment strategies and biological mechanisms associated with tissue protection and disease management.[3]

Publications

  • Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis (2021).[3]
  • Additional collaborative studies addressing biomedical and clinical research themes indexed within Scopus.[1]

Research Impact

The citation performance associated with Janaina Lemos’s publications indicates that her research has been referenced by a broad range of scholarly works. Citation activity from more than one hundred citing documents reflects ongoing academic engagement with her findings and supports the relevance of her contributions within contemporary biomedical research.[1]

Award Suitability

The Best Researcher Award recognizes individuals who demonstrate measurable scholarly impact, publication quality, and sustained commitment to scientific advancement. Based on available bibliometric indicators, publication record, and research influence, Janaina Lemos demonstrates characteristics consistent with the objectives of academic recognition programs dedicated to research excellence and knowledge dissemination.[4]

Conclusion

Janaina Lemos maintains a documented research profile characterized by peer-reviewed publications, interdisciplinary collaboration, and measurable citation impact. Her scholarly activities contribute to ongoing developments in medicine and health sciences, supporting her recognition as a researcher whose work continues to inform scientific understanding and healthcare research.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Janaina Lemos, Author ID 50262115100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=50262115100
  2. Scopus Database. (n.d.). Research metrics and publication records in health sciences.
  3. Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis(2021)
    https://www.sciencedirect.com/science/article/pii/S240584402100863X
  4. Computer Scientists Awards. (n.d.). Best Researcher Award evaluation criteria.
    https://computerscientists.net/
  5. Janaina Lemos Journal. (2021). Biomedical and translational research publication record.

Anna Iwan | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Dr. Anna Iwan | Medicine | Research Excellence Award

University Clinical Hospital No.4 | Poland

Dr. Anna Iwan is a dedicated clinical oncology and internal medicine specialist with a strong focus on patient-centered cancer care, emergency medicine, and interdisciplinary clinical practice. Her professional work reflects continuous advancement in oncology treatment approaches, particularly in gynecological oncology and radiotherapy, combined with a commitment to improving patient outcomes through compassionate care and effective communication. She demonstrates strong teamwork, clinical decision-making, and empathetic patient management. Although primarily focused on clinical practice, her research visibility across Scopus and Google Scholar remains limited, with minimal indexed publications, resulting in currently low citation counts, document records, and an emerging h-index, indicating potential for future academic and research contributions.

View ORCID Profile

Featured Publications

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Assistant Professor | University of Cagliari | Italy

Assist. Prof. Dr. Simona Dedoni is a researcher specializing in pharmacology, industrial biochemistry, and antiviral drug development, with a strong focus on molecular mechanisms of neurotoxicity and interferon-induced cellular responses. Her work contributes to understanding drug interactions, therapeutic pathways, and biomedical applications in disease treatment. She has established a significant scientific presence through high-impact publications and interdisciplinary research. According to Scopus data, she has 912 citations across 51 documents with an h-index of 19, reflecting strong academic influence, while her Google Scholar profile further indicates sustained citation growth and research visibility in pharmacological and biomedical sciences.

Citation Metrics

1000

800

600

400

200

0

 

Citations
912

Documents
51

h-index
19

                               ■ Citations
■ Documents
■ h-index


View Scopus Profile View ORCID Profile

Featured Publications

Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Professor/ Senior Researcher | University of Medical Sciences of Havana | Cuba

Prof. Dr. Dachel Martínez Asanza is a distinguished Cuban scholar and senior researcher in the field of dental sciences and medical education, recognized for her interdisciplinary expertise in comprehensive dentistry, health promotion, epidemiology, and pedagogical innovation in medical education. Her academic pursuits bridge clinical dentistry with public health, emphasizing preventive oral care, biopsychosocial health management, and the integration of digital and natural medicine within community health frameworks. A full professor at the University of Medical Sciences of Havana, Dr. Asanza has made substantial contributions to advancing dental education through work-based learning methodologies and curriculum development in health sciences. Her research explores the intersection of technology, digital health, and education, reflecting a deep commitment to enhancing healthcare delivery and educational practices in dentistry. With a Scopus record of 26 indexed publications, over 143 citations from 107 documents, and an h-index of 7, alongside Google Scholar metrics of 371 total citations, an h-index of 11, and an i10-index of 12, Dr. Asanza’s scholarly impact is widely recognized. Her works are featured in reputed international journals, often addressing themes such as digital health adoption, green innovation, and AI applications in healthcare.

Profile

Scopus | ORCID | Google Scholar

Featured Publications

  • Golmankhaneh, A. K., Tunç, S., Schlichtinger, A. M., & Martínez Asanza, D. (2024). Modeling tumor growth using fractal calculus: Insights into tumor dynamics. Biosystems, 235, 105071.

  • Kamel Mouloudj, A. B., Bouarar, A. C., Martínez Asanza, D., & Linda, M. (2023). Factors influencing the adoption of digital health apps: An extended technology acceptance model (TAM). Integrating Digital Health Strategies for Effective Administration, 116–132.

  • Martínez Asanza, D. (2018). Traditional teaching in the 21st century? Neuronum Magazine, 4(1), 99–106.

  • Martínez-Asanza, D. (2021). Regarding work-based learning, a guiding principle of Cuban medical education. FEM: Journal of the Medical Education Foundation, 24(6), 325–325.

  • Njoku, A., Mouloudj, K., Bouarar, A. C., Evans, M. A., & Martínez Asanza, D. (2024). Intentions to create green start-ups for collection of unwanted drugs: An empirical study. Sustainability, 16(7), 2797.

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

  • Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.

  • Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.

  • Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.

  • Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.

  • Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.